The point-of-care (PoC) testing of virus DNA or antibodies is considered the holy grail of medical diagnostics. The idea however, is relatively simple: a sample is taken and the test is performed near patient and within minutes you have a result. With highly infectious diseases such as covid-19 being able to test on the spot at e.g. in a patient's home can be life saving, and there is no time-consuming and expensive lab work involved.
The aim is to have SARS-CoV-2 testing devices in doctors’ offices, which yield reliable test results within 5 minutes. The device will be built around a photonic biochip using LioniX International’s mature and proven silicon nitride based integrated optics technology (TriPleX™). The surface functionalization and biochemical assay development are provided by Surfix and Qurin Diagnostics, respectively.